Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A comparative study of 25 mcg vs 50 mcg of vaginal misoprostol for induction of labour

View through CrossRef
Background: The objectives of the current study were to compare the efficacy and safety of 25μg and 50μg of intravaginal misoprostol for induction of labor at term and to study the maternal and fetal outcome.Methods: A Prospective Study was done on 50 cases with 25μg misoprostol and 50 cases of 50μg of misoprostol intravaginal, repeated every 6 hourly till adequate uterine contractions or maximum 5 doses. Total dose of induction, induction delivery interval, mode of delivery, maternal and fetal outcome were recorded.Results: Mean induction delivery interval was 13.8±5.9 and 14.0±5.7 hours (P=0.9) with the 25μg and 50μg misoprostol respectively. The 25μg misoprostol group had a lower delivery rate with a single dose compared with the 50μg group (38% and 42% respectively). However, 25μg group had more deliveries than 50μg group with increasing number of misoprostol doses (36% vs. 38%, and 20% vs. 16% for 2 doses and 3 doses respectively). The need for oxytocin augmentation among participants was higher in the 25μg group (20%) than in 50 μg group (16%).This was however not statistically significant (P=0.603). At lesser initial bishop score, with 50µg misoprostol less doses are needed as compared to 25 µg and hence induction delivery interval decreases. The rates of caesarean section and operative vaginal delivery were similar in both groups. There was no significant difference in maternal side effects and neonatal outcomes among the women in the two groups.Conclusions: The 25 µg of intravaginal misoprostol administered six‑hourly appears to be as effective but safer than 50 µg for induction of labor. The use of 50 µg misoprostol may be recommended when there is a need to expedite vaginal delivery especially in cases of lesser initial bishop score.
Title: A comparative study of 25 mcg vs 50 mcg of vaginal misoprostol for induction of labour
Description:
Background: The objectives of the current study were to compare the efficacy and safety of 25μg and 50μg of intravaginal misoprostol for induction of labor at term and to study the maternal and fetal outcome.
Methods: A Prospective Study was done on 50 cases with 25μg misoprostol and 50 cases of 50μg of misoprostol intravaginal, repeated every 6 hourly till adequate uterine contractions or maximum 5 doses.
Total dose of induction, induction delivery interval, mode of delivery, maternal and fetal outcome were recorded.
Results: Mean induction delivery interval was 13.
8±5.
9 and 14.
0±5.
7 hours (P=0.
9) with the 25μg and 50μg misoprostol respectively.
The 25μg misoprostol group had a lower delivery rate with a single dose compared with the 50μg group (38% and 42% respectively).
However, 25μg group had more deliveries than 50μg group with increasing number of misoprostol doses (36% vs.
38%, and 20% vs.
16% for 2 doses and 3 doses respectively).
The need for oxytocin augmentation among participants was higher in the 25μg group (20%) than in 50 μg group (16%).
This was however not statistically significant (P=0.
603).
At lesser initial bishop score, with 50µg misoprostol less doses are needed as compared to 25 µg and hence induction delivery interval decreases.
The rates of caesarean section and operative vaginal delivery were similar in both groups.
There was no significant difference in maternal side effects and neonatal outcomes among the women in the two groups.
Conclusions: The 25 µg of intravaginal misoprostol administered six‑hourly appears to be as effective but safer than 50 µg for induction of labor.
The use of 50 µg misoprostol may be recommended when there is a need to expedite vaginal delivery especially in cases of lesser initial bishop score.

Related Results

Efficacy of Vaginal Misoprostol and Intracervical Catheterization in Labour Induction for Vaginal Delivery in Eclampsia Patients
Efficacy of Vaginal Misoprostol and Intracervical Catheterization in Labour Induction for Vaginal Delivery in Eclampsia Patients
Background: Eclampsia, a severe complication of pregnancy characterized by seizures, remains a significant cause of maternal and neonatal morbidity and mortality. Effective and saf...
Potentially acute misoprostol toxicity during third-trimester pregnancy: a case report
Potentially acute misoprostol toxicity during third-trimester pregnancy: a case report
Background: The International Federation of Gynecology and Obstetrics (FIGO) recommends the dosage of misoprostol for pregnancy termination in >28 weeks is 25 mcg to 100 mcg per...
Comparison of oral versus vaginal misoprostol for medical management of early fetal demise at Akhtar Saeed Trust Hospital, Lahore.
Comparison of oral versus vaginal misoprostol for medical management of early fetal demise at Akhtar Saeed Trust Hospital, Lahore.
Objective: To compare the efficacy, safety, and clinical outcomes of oral versus vaginal misoprostol for medical management of first-trimester missed abortion at Akhtar Saeed Trust...
Primerjalna književnost na prelomu tisočletja
Primerjalna književnost na prelomu tisočletja
In a comprehensive and at times critical manner, this volume seeks to shed light on the development of events in Western (i.e., European and North American) comparative literature ...
Kajian penggunaan obat misoprostol sebagai off-label pada pelaksanaan persalinan di Klinik Utama Al-Islam Bandung
Kajian penggunaan obat misoprostol sebagai off-label pada pelaksanaan persalinan di Klinik Utama Al-Islam Bandung
Abstrak Misoprostol sebagai off-label sering digunakan dalam tindakan persalinan baik untuk induksi persalinan maupun untuk pencegahan perdarahan pasca persalinan. Perdarahan pasca...
Misoprostol for non-alcoholic steatohepatitis: a randomised control trial
Misoprostol for non-alcoholic steatohepatitis: a randomised control trial
Introduction The management of non-alcoholic steatohepatitis (NASH) is an unmet clinical need. Misoprostol, a structural analogue of naturally occurring prostagla...

Back to Top